# A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions

Study · id `cardio:ct-nct01760083` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01760083](<https://clinicaltrials.gov/study/NCT01760083>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01760083

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 450 participants.

## Technical summary

Registry record NCT01760083. Randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2016-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 450 participants (enrolled count; ClinicalTrials.gov record NCT01760083, source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)
- Started: 2013-01 (actual) (ClinicalTrials.gov record NCT01760083, source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)
- Primary completion: 2016-05 (actual) (ClinicalTrials.gov record NCT01760083, source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)
- Completion: 2018-11 (actual) (ClinicalTrials.gov record NCT01760083, source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)
- Countries: France; Germany; Italy; Latvia; Spain; United Kingdom (ClinicalTrials.gov record NCT01760083, source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01760083-2019-07-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
- Acronym: EuroCTO
- Condition: Chronic Stable Angina
- Condition: Dyspnea
- Condition: Coronary Occlusion
- Intervention (Device): Biolimus-eluting stent implantation
- Lead sponsor: Euro CTO Club
- Lead sponsor class: OTHER
- Collaborator: NHS Research and Development
- Collaborator class: OTHER\_GOV
- Collaborator: Biosensors International
- Collaborator class: OTHER
- Collaborator: Asahi Intecc Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as a collaborator: Biosensors International (`cardio:org-biosensors-international`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions (`cardio:pubmed-29722796`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO) (`cardio:pubmed-37482940`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6bf127e74465a56d44e80832e8ad61128ca0993e12624b0286db7764135c6d99
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
